Summary of published data on outcomes of patients with pulmonary arterial hypertension bridged to lung transplant with the use of extracorporeal life support devices
| First author [ref.] | Patients who received ECMO support | Patients bridged to transplant | Patients discharged from hospital |
| de Perrot [30] | 6 (4 PA-LA, 2 VA ECMO) | 6/6 (100%) | 4/6 (66%) |
| Fuehner [39] | 7 (all VA ECMO) | 6/7 (86%) | 5/6 (71%) |
| Hoopes [73] | 5 (all VA ECMO) | 5/5 (100%) | 5/5 (100%) |
| Lang [74] | 4 (all VA ECMO) | 4/4 (100%) | 4/4 (100%) |
| Rosenzweig [41] | 6 (all VA ECMO) | 2/2 (100%); 4 received ECMO as bridge to recovery | 2/2 (100%); 1/4 (25%) bridge to recovery patients survived for >2 months |
| Shafii [75] | 3 (all VA ECMO) | 2/3 (66%) | 2/2 (100%) |
| Crotti [76] | 4 (3 VA ECMO, 1 VV ECMO) | 4/4 (100%) | 3/4 (75%) |
| Hoetzenecker [77] | 13 (9 PA-LA, 4 VA ECMO) | 11/13 (85%) | 7/11 (63%) survived at 1 year |
| Savale [56] | 13 (all VA ECMO) | 13/13 (100%) | 8/13 (62%) |
| Dellgren [78] | 2 (both VA ECMO) | 2/2 (100%) | 1/2 (50%) |
| Glorion [79] | 18 (13 VA ECMO, 3 VV ECMO, 2 PA-LA) | 17/18 (94%) | 15/17 (88%) |
| Total | 81 (66 ECMO, 15 PA-LA); 77 as bridge to transplant | 72/77 (94%) | 56/72 (78%) |
ECMO: extracorporeal membrane oxygenation; PA-LA: pulmonary artery to left atrium device; VA: veno-arterial; VV: veno-venous.